Back to Results
First PageMeta Content
Epidemiology / Clinical research / Design of experiments / Evaluation methods / Medical statistics / Randomized controlled trial / Clinical trial / Confidence interval / Chlamydia infection / Statistics / Science / Information


50795 Doxycycline Statistical PREA
Add to Reading List

Open Document

File Size: 131,44 KB

Share Result on Facebook

City

Reference / /

Company

Wilson / SPECIAL/SUBGROUP / EXECUTIVE SUMMARY Warner Chilcott LLC / Warner Chilcott LLC / ITT / /

Event

FDA Phase / Product Recall / Product Issues / /

IndustryTerm

study protocol / healthcare providers / /

MedicalCondition

C. trachomatis infection / genital chlamydial infections / primary deficiency / persistent Chlamydia infection / uncomplicated urogenital C. trachomatis infection / Uncomplicated Urogenital Chlamydia trachomatis Infection / infection / untreated infection / MS / C. trachomatis infections / /

Organization

U.S. Department of Health and Human Services / Translational Sciences Office / FDA / Biometrics Division / Food and Drug Administration Center for Drug Evaluation / Research Office / Medical Division / Division of Anti-infective Products / /

Person

Carmen Debellas / John Alexander / Daphne Lin / Dmitri Iarikov / Concurring Reviewers / Meg Gamalo / Lillian Patrician / Thamban Valappil / Edward Cox / /

Position

Director of OAP / Project Manager / Statistical Team Leader / /

Product

DORYX / patients / azithromycin / Doxycycline / doxycycline hyclate / Vibramycin / WC2031 / C. / indication / /

Technology

study protocol / analysis protocol / /

SocialTag